Author(s): Liesenfeld O, Lehman L, Hunfeld KP, Kost G
Abstract Share this page
Abstract By shortening the time to pathogen identification and allowing for detection of organisms missed by blood culture, new molecular methods may provide clinical benefits for the management of patients with sepsis. While a number of reviews on the diagnosis of sepsis have recently been published we here present up-to-date new developments including multiplex PCR, mass spectrometry and array techniques. We focus on those techniques that are commercially available and for which clinical studies have been performed and published.
This article was published in Eur J Microbiol Immunol (Bp)
and referenced in Journal of Medical Microbiology & Diagnosis